New Jersey Laws & Regulations
The information contained on this website is provided for informational purposes only and should not be construed as legal advice on any matter. The Information constitutes general information of applicable administrative regulation and/or laws related to general topics in the arena of controlled substance misuse and abuse and may not reflect current legal developments and updates. Please refer to your state legislature for any potential changes.
Menu
NJ Statutes Annotated (NJSA)
NJ Administrative Code (NJAC)
New Jersey Advertising/Marketing Information
- N.J.A.C. 13:39-7.14 – Advertising and sale of prescription drugs
- N.J.A.C. 17:30A-12.1 – Marketing and advertising (Medicinal Marijuana)
- NJSA Sec. 2C:36-4 – Advertising to promote sale, crime of fourth degree
- NJSA Sec. 24:6E-2 – Advertisement of prescription drugs; rules and regulations
- NJSA Sec. 24:6I-35 – Regulation of cannabis.
New Jersey Child Safety Information
- DCF – Child Abuse and Neglect Laws
- NJSA Sec. 2C:36-5 – Delivering drug paraphernalia to person under 18 years of age, crime of third degree
New Jersey Compounding Information
- N.J.A.C. Sec. 13:39 Subchapter 11 – Compounding Sterile Preparations in Retail and Institutional Pharmacies
- N.J.A.C. Sec. 13:39 Subchapter 11A – Compounding Non-Sterile Preparations in Retail and Institutional Pharmacies
New Jersey Coroner/Medical Examiner Information
- N.J.A.C. Title 8 Chapter 70 – Chief State Medical Examiners Rules
- CDC – New Jersey Coroner/Medical Examiner Laws
New Jersey Drug Checking Information (Test Strips)
- NJSA Sec. 2C:36-1 – Drug paraphernalia, defined; determination.
- NJSA Sec. 2C:36-2 – Use or possession with intent to use.
New Jersey Drug Cleanup Information (Methamphetamine & Fentanyl Labs)
- NJSA Sec. 58:10-23.11 – Spill Compensation and Control Act
- NJSA Sec. 58:10-23.11a – Findings and declarations
New Jersey Drug Court Information
- NJSA Sec. 2C:35-14 – Rehabilitation program for persons with a substance use disorder.
- NJSA Sec. 2C:35-14.2 – Sentence of special probation for certain defendants.
- NJSA Sec. 2C:35-15 – Mandatory drug enforcement and demand reduction penalties; collection; disposition; suspension.
New Jersey Drug Free Workplace Information
- NO STATE SPECIFIC PROGRAMS OR INFORMATION IDENTIFIED
New Jersey Drugged Driving Information
- NJSA Sec. 39:4-50 – Driving while intoxicated. [ Sec. 39:4-50 thru 39:4-50.23]
New Jersey Drug Violations Information
- NJSA Sec. 2C:35-1 thru 2C:35-31 – known as the “Comprehensive Drug Reform Act of 1987.”
- NJSA Sec. 2C:35-8 – Distribution to persons under age 18; enhanced punishment
- NJSA Sec 2C:35-9(a) – Strict Liability for Drug-Induced Deaths
- NJSA Title 24 – Food and Drugs
New Jersey Electronic Prescribing Information
-
N.J.A.C. 13:35-7.4A – Electronically transmitted prescriptions
-
N.J.A.C. 13:39-7.11 – Electronically transmitted prescriptions
- 2024-2025 SB 1131 – An Act concerning Internet pharmacies and electronic prescriptions, amending and supplementing P.L.2003, c.280 (C.45:14-40 et seq.). (Pending)
New Jersey First Responder Deflection Program(s) Information
- NJSA Sec. 30:6C-12 – Establishment of law enforcement assisted addiction and recovery referral program.
- NJSA Sec. 30:6C-13 – Participation upon approval by governing body.
- NJSA Sec. 30:6C-14 – Determination of eligibility for participation.
- NJSA Sec. 30:6C-15 – Compliance with requirements.
- NJSA Sec. 30:6C-16 – Immunity from liability.
New Jersey 911 – Good Samaritan Information
- NJSA Sec. 2C:35-30 – Immunity from liability, certain circumstances, for persons seeking medical assistance for someone experiencing a drug overdose.
- NJSA Sec. 2C:35-31 – Protections for certain persons experiencing a drug overdose.
- NJSA Sec. 24:6J-4 – Immunity from liability for certain prescribers, practitioners, dispensers.
New Jersey Medical Marijuana, Recreational Marijuana & CBD Information
- N.J.A.C. 2:25 – New Jersey Hemp Program Rules
- NJSA Title 24 – Food and Drugs [Sec. 24:6I-1 thru Sec. 24:6I-56]
- NJSA Sec. 24:6I-35 – Regulation of cannabis.
- Cannabis Regulatory Commission – Cannabis Related Laws
- Marijuana Policy Project – New Jersey
New Jersey Medication Assisted Treatment (MAT) Information
- N.J.A.C. Sec. 10:161B – Subchapter 11 – Opioid Treatment Services
-
N.J.A.C. 13:35-7.7 – Prohibitions on prescribing, administering or dispensing of controlled substances for detoxification; limited exceptions
- NJSA Sec. 2C:45-5 – Medication -assisted treatment
- NJSA Sec. 26:2G-21 – Narcotic and drug abuse treatment centers; public policy
- NJSA Sec. 26:2G-22 – Definitions.
- NJSA Sec. 26:2G-23 – Certificate of approval; application.
- NJSA Sec. 26:2G-25 – Rules, regulations, minimum standards for treatment.
- NJSA Sec. 26:2G-34 – Program of medical and community services.
- NJSA Sec. 26:2H-11.1 – Requirements for applicants for certificate of need, initial licensure for certain facilities.
New Jersey Naloxone Information
- NJSA Sec. 24:6J-1 thru Sec. 24:6J-7 – Opioid Prevention Act
- NJSA Sec. 18A:40-12.23 – Definitions relative to the emergency administration of opioid antidotes in schools.
- NJSA Sec. 18A:40-12.24 – Development of school policy for emergency administration of opioid antidotes.
- NJSA Sec. 18A:40-12.25 – Guidelines for development of policy.
- NJSA Sec. 18A:40-12.26 – Immunity from liability.
- NJSA Sec. 18A:40-12.27 – Shared services arrangement.
- NJSA Sec. 24:6J-4 – Immunity from liability for certain prescribers, practitioners, dispensers.
- NJSA Sec. 26:5C-28 – Establishment, authorization by municipality of certain programs.
New Jersey Needle Exchange Programs (NEP) & Syringe Services programs (SSP) Information
- NJSA Sec. 2C:36-1 – Drug paraphernalia, defined; determination.
- NJSA Sec. 2C:36-2 – Use or possession with intent to use.
- NJSA Sec. 2C:36-4 – Advertising to promote sale, crime of fourth degree
- NJSA Sec. 2C:36-5 – Delivering drug paraphernalia to person under 18 years of age, crime of third degree
- NJSA Sec. 2C:36-6a – Possession of hypodermic syringe, needle under certain circumstances not an offense.
- NJSA Sec. 26:5C-25 – Short title.
- NJSA Sec. 26:5C-26 – Findings, declarations relative to sterile syringe access programs.
- NJSA Sec. 26:5C-26.1 – Definitions.
- NJSA Sec. 26:5C-27 – Operation of sterile syringe access program.
- NJSA Sec. 26:5C-28 – Establishment, authorization by municipality of certain programs.
- NJSA Sec. 26:5C-29 – Reports to Governor, Legislature.
New Jersey Neonatal Abstinence Syndrome (NAS), Neonatal Opioid Withdrawal (NOWS) Information
- N.J.A.C. Sec. 3A:26-1 thru 3A:26-1.3 – Reports of Substance-Affected Infants
-
N.J.A.C. 8:43G-2.13 – Child abuse and neglect and substance-affected infants
New Jersey Opioid Litigation Proceeds Information
- NJSA Sec. 26:2G-39 – “Opioid Recovery and Remediation Fund” established; Department of the Treasury.
- NJSA Sec. 26:2G-40 – “Opioid Recovery and Remediation Advisory Council” established, Department of Human Services.
- P.L. 2023 (c. 25) – SB 783 – An Act Concerning the dedication and distribution of funds received from opioid settlements and supplementing Title 26 (Approved 3/17/2023)
New Jersey Overdose Prevention Centers (OPC), Supervised Consumption Sites (SCS), Supervised Injection Facilities (SIF) Information
- NO STATE SPECIFIC PROGRAMS OR INFORMATION IDENTIFIED
New Jersey Overdose Surveillance/Reporting Information
- NJSA Sec. 26:3A2-20.3 thru 26:3A2-20.10 – Creating a local overdose fatality review team, et al
New Jersey Pain Management Information
-
N.J.A.C. 8:43E-6.1 – Pain Management Procedures [Sec. 8:43E-6.1 thru sec. 8:43E-6.6]
-
N.J.A.C. 13:35-7.6 – Limitations on prescribing, administering, or dispensing of controlled dangerous substances; special requirements for management of acute and chronic pain
- NJSA Sec. 45:1-46.1 – Proper time to access prescription monitoring information; restrictions in dispensing certain controlled dangerous substances; exceptions.
New Jersey Pill Press & Counterfeit Medication Information
- NJSA Sec. 2C:35-11 – Imitation controlled dangerous substances; distribution, possession, manufacture, etc.; penalties
- NJSA Sec. 2C:35-11.1 – Counterfeit drugs, medical devices; degree of crime; definitions.
- NJSA Sec. 24:21-22 – Prohibited acts D.–Fraud or misrepresentation by registered manufacturers or distributors–penalties.
- NO STATE SPECIFIC PROGRAMS OR INFORMATION IDENTIFIED FOR PILL PRESSES
New Jersey Prescription Drug Drop-Off Information
- NJSA Sec. 24:21-55 – “Project Medicine Drop” program.
New Jersey Prescription Drug Importation Information
- NO STATE SPECIFIC PROGRAMS OR INFORMATION IDENTIFIED
New Jersey Prescription Drug Monitoring Program Information
- NJSA Sec. 45:1-44 thru Sec. 45:1-50.1 – Prescription Monitoring Program. Definitions, et al
- NJSA Sec. 26:2H-81.1 – Definitions relative to hospice care, disposal of unused prescription medications.
- NJSA Sec. 26:16-12 – Disposal of medication if patients chooses not to self-administer.
New Jersey Precursor Chemicals/Including Pseudoephedrine Information
- NJSA Sec. 2C:35-25 – Sale restrictions for ephedrine products; disorderly persons offense.
- NJSA Sec. 2C:35-26 – Reporting requirement for ephedrine products.
- NJSA Sec. 2C:35-27 – Permissive inference concerning possession of ephedrine products.
- NJSA Sec. 2C:35-28 – Unlawful possession of precursors; manufacturing methamphetamine; crime of second degree.
- NJSA Sec. 2C:35-29 – Definitions relative to industrial use of certain chemicals; not deemed a CDS, certain; inferences.
New Jersey Prison/Jail Program(s) Information
- NJSA Sec. 2C:35-14 – Rehabilitation program for persons with a substance use disorder.
- NJSA Sec. 30:4-82.2 – Provision of mental health, substance abuse disorder services to inmates.
- NJSA Sec. 30:6C-12 – Establishment of law enforcement assisted addiction and recovery referral program.
New Jersey School Programs/Information
- NJSA Sec. 18A:40-12.22 – Policy for administration of medical cannabis to student.
- NJSA Sec. 18A:40-12.23 – Definitions relative to the emergency administration of opioid antidotes in schools.
- NJSA Sec. 18A:40-12.24 – Development of school policy for emergency administration of opioid antidotes.
- NJSA Sec. 18A:40-12.25 – Guidelines for development of policy.
- NJSA Sec. 18A:40-12.26 – Immunity from liability.
- NJSA Sec. 18A:40-12.27 – Shared services arrangement.
- NJSA Sec. 18A:40A-1 thru Sec. 18A:40A-22 – Instructional programs on drugs, alcohol, anabolic steroids, tobacco and controlled dangerous substances; curriculum guidelines; et al
- 2018 Chapter 106 amending P.L.2013, c.46 – AN ACT concerning the emergency administration of opioid antidotes in schools…
New Jersey Sober Living Homes/Recovery Residence Information
- NJSA Sec. 26:2B-15 – Procedures for admission, treatment at a facility.
- NJSA Sec. 26:2G-25 – Rules, regulations, minimum standards for treatment.
New Jersey Substance Abuse Services Information
- N.J.A.C. Sec. 10:161B – Subchapter 11 – Opioid Treatment Services
- NJSA Sec. 2C:35-14 – Rehabilitation program for persons with a substance use disorder.
- NJSA Sec. 2C:45-5 – Medication -assisted treatment
- NJSA Sec. 26:2G-21 – Narcotic and drug abuse treatment centers; public policy
- NJSA Sec. 26:2G-22 – Definitions.
- NJSA Sec. 26:2G-23 – Certificate of approval; application.
- NJSA Sec. 26:2G-25 – Rules, regulations, minimum standards for treatment.
- NJSA Sec. 26:2G-34 – Program of medical and community services.
- NJSA Sec. 26:2H-11.1 – Requirements for applicants for certificate of need, initial licensure for certain facilities.
- NJSA Sec. 30:4-82.2 – Provision of mental health, substance abuse disorder services to inmates.
- NJSA Sec. 30:6C-12 – Establishment of law enforcement assisted addiction and recovery referral program.
New Jersey Telemedicine/Telehealth Information
- NJSA Sec. 45:1-61 – Definitions relative to telemedicine and telehealth.
- NJSA Sec. 45:1-62 – Provision of health care through use of telemedicine, telehealth; requirements for provider.
- NJSA Sec. 45:1-63 – Establishment of proper provider-patient relationship; exceptions.
- NJSA Sec. 45:1-64 – Annual registration, report.
- NJSA Sec. 45:1-65 – Telemedicine and Telehealth Review Commission.
Last Updated – 8/14/2024
Please report any broken links to tech@naddi.org
